Tag Archives: MEQ

Exadel Announces Appery.io COVID-19 Virtual Hackathon to Engage Global Developer Community

Global hackathon invites developers to build digital solutions designed to support individuals and businesses during coronavirus pandemic

WALNUT CREEK, Calif., April 22, 2020 /PRNewswire/ — Exadel (www.exadel.com), a global provider of digital platform engineering solutions and services, today announced it will be hosting the “Appery.io COVID-19 Virtual Hackathon” that invites developers from all over the world to build digital solutions that solve challenges posed by the Coronavirus. The Appery.io COVID-19 Virtual Hackathon begins April 22, 2020 at 9 a.m. PDT with final submissions due May 6, 2020 by 11:59 p.m. PDT. Applications will be judged by a panel of experts with up to $1,000 in cash prizes awarded.

Sign-up for the Appery.io COVID-19 Virtual Hackathon today: (https://covid.appery.io/)

Using Appery.io, a low-code application development platform created by Exadel and used by nearly 500,000 developers worldwide, participants are encouraged to build applications that help groups and businesses most impacted by COVID-19. Projects should focus on areas like healthcare, mental health, assistance for the elderly or vulnerable, improving remote work, financial stability or maintaining a sense of community. Developers are free to be as innovative and unique as possible with minimal restrictions on application type or theme.

Participants are welcome to register and submit their applications starting April 22, 2020. Submissions close May 6, 2020 and will be judged by a panel of experts according to a range of relevant criteria. A virtual, live ceremony will take place on May 10, 2020 where finalists will be recognized. Prizes will be awarded as follows:

  1. First-Place – $1,000 and an Appery.io Annual Pro Subscription
  2. Second-Place – $500 and an Appery.io Annual Pro Subscription
  3. Third-Place – $250 and an Appery.io Annual Pro Subscription

For more information on how to get started, FAQ’s and guidelines please visit: (https://covid.appery.io/)

“While physical interaction is being limited in many global communities, it’s important to find ways to connect and support one another in alternative settings,” said Fima Katz, CEO and President of Exadel. “By hosting this hackathon, we hope to bring together the developer community in a meaningful way where they can innovate and experiment with projects aimed at helping those who need it most. We look forward to reviewing and gaining inspiration from the submissions.”

Tweet this: .@exadel announces @apperyio COVID-19 Virtual Hackathon to bring together community to build projects aimed at solving common challenges faced today #ApperyHackathon

About Exadel

Exadel is a leading digital platform engineering services provider. Through technical software development, Exadel helps Fortune 500 clients accelerate their digital transformations by providing innovative solutions, services and engineering expertise. Exadel enables clients to engage competitively with their customers by delivering products and platforms at optimal efficiency. With 20+ locations and delivery centers across the US and Europe, Exadel solves the most complex engineering problems using recognized agile practices, offering a high-quality and skilled mix of multi-shore resources with deep knowledge of advanced technologies. 

About Appery.io

Appery.io is a low-code, rapid development, integration and deployment platform created by Exadel for delivering cross-device apps in the enterprise. It combines enterprise-grade integration middleware with a browser-based rapid development environment and mobile backend services to accelerate enterprise mobilization. Appery.io enables developers and business analysts to rapidly create and run apps that help businesses of all sizes increase revenues and improve productivity.

Media Contact:
Olivia Heel
Catapult PR-IR
303-581-7760
oheel@catapultpr-ir.com

Logo – https://techent.tv/wp-content/uploads/2020/04/exadel-announces-appery-io-covid-19-virtual-hackathon-to-engage-global-developer-community.jpg

Vela Diagnostics receives BARDA funding to develop COVID-19 tests

FAIRFIELD, N.J., April 20, 2020 /PRNewswire/ — Vela Diagnostics has been awarded a $225,000 contract by the Biomedical Advanced Research and Development Authority (BARDA) part of the office of the Assistant Secretary for Preparedness and Response at the U.S. Department of Health and Human Services, to develop manual and automated tests to detect SARS-CoV-2, the virus that causes COVID-19.

The ViroKey™ SARS-CoV-2 RT-PCR Test is a probe-based reverse transcription PCR test that detects the virus by targeting conserved regions of the SARS-CoV-2 genome.

Under the agreement, Vela Diagnostics will perform verification and clinical validation of the ViroKey™ SARS-CoV-2 RT-PCR Test to be used on automated and manual workflows for Emergency Use Authorization (EUA) submission to the U.S. Food and Drug Administration (FDA). Support from BARDA is expected to accelerate the progress toward EUA submission.

The automated ViroKey™ SARS-CoV-2 RT-PCR Test is performed on a workflow consisting of the Sentosa™ SX101 instrument, in conjunction with the Applied Biosystems 7500 Fast Dx Real-Time (ABI 7500 Fast Dx) PCR instrument or the Sentosa™ SA201 instrument.

Up to 48 samples (including positive and negative controls) can be processed per run on the automated workflow. The manual assay was developed to enable flexible sample processing and quick adoption of the test by laboratories with existing ABI 7500 Fast Dx instruments.

High volume testing of SARS-CoV-2 is also critical in mitigating the rapidly evolving COVID-19 pandemic. The CDC recommends COVID-19 testing for individuals with symptoms associated with COVID-19 such as fever and acute respiratory illness.

“High throughput detection of SARS-CoV-2 using our automated workflow will provide rapid and valuable information to save lives,” said Sam Dajani, acting CEO and chairman of the Board. “The funding from BARDA will enable Vela Diagnostics to increase the domestic and global testing capacity for COVID-19 to curb further spread of the virus.”

“Rapid diagnostic tests put essential information into the hands of healthcare providers and patients to manage patient care safely and appropriately.  Data gathered from high-throughput testing aids public health officials in making decisions about community mitigation to combat the pandemic,” said BARDA Director Rick Bright, Ph.D.

To date, COVID-19 has affected 199 countries and territories around the world, with total cases exceeding a million in US, Europe and China combined and at least 100,000 fatalities worldwide. On March 11, the World Health Organization declared COVID-19 to be a pandemic.

This project has been funded in whole or in part with federal funds from the Department of Health and Human Services; Office of the Assistant Secretary for Preparedness and Response; Biomedical Advanced Research and Development Authority, Division of Research Innovation and Ventures under Contract No. 75A50120C00039.

About Vela Diagnostics

Vela Diagnostics is a leading provider of an automated IVD Next–Generation Sequencing (NGS) workflow in the global diagnostics market. VELA’s real-time PCR and NGS applications are available on an integrated Sentosa™ platform; this provides a unique ability to leverage one system for two workflows, while carrying out tests for various targets in order to answer current clinical and research questions, as well as to drive laboratory operational efficiency.

All Sentosa™ products listed above are by Vela Diagnostics. For more information, visit www.veladx.com.

Cision View original content:http://www.prnewswire.com/news-releases/vela-diagnostics-receives-barda-funding-to-develop-covid-19-tests-301043313.html

Charoen Pokphand Group Launches Surgical Mask Factory along with Multi-Pronged Initiatives against COVID-19

  • Production starts today at surgical mask factory in Bangkok, producing 100,000 masks per day
  • Pledged to save jobs across the Group, along with medical, food and education support for employees
  • Donated USD 29.14 Million in Thailand to tackle COVID-19

BANGKOK, April 17, 2020 /PRNewswire/ — To tackle the COVID-19 pandemic, Charoen Pokphand Group (C.P. Group) announces a series of measures focused on supporting its employees, consumers, and the local community, especially healthcare workers. The multi-pronged initiatives include building a surgical mask factory to provide essential medical supplies, preserving jobs across the Group, delivering food and essential supplies to frontline healthcare workers and enhancing digital infrastructure to enable more efficient e-learning and remote working. To date, the Group has contributed donations worldwide to tackle COVID-19, with donations to Thailand totaling USD 29.14 Million, including for the procurement of medical supplies and protective equipment for hospitals.

The Group’s initiatives include the following key areas in Thailand:

  • Launched Surgical Mask Factory: C.P. Group invested USD 3 million (100 million baht) to build a factory just outside Bangkok to produce medical-grade surgical masks in Thailand. The factory was built in 5 weeks during COVID-19 and has obtained regulatory approval from Thai authorities to start producing surgical masks today, with production reaching 100,000 masks per day which totals to 3 million masks per month. The masks will be donated for free to medical professionals and healthcare workers throughout Thailand’s hospitals. When the COVID-19 crisis subsides, the ownership of the factory will be transferred to one of Bangkok’s public hospitals.
  • Support to employees: Mr. Suphachai Chearavanont, the CEO of C.P. Group announced on April 8th, 2020 to staff that the Group is committed to not making layoffs as a result of COVID-19 across the Group worldwide, and will work together with its subsidiaries in accordance with local laws and regulations. In addition, the Group will cover medical expenses to treat COVID-19, provide education loans for their employees’ children, and provide food to quarantined employees who are negatively impacted by COVID-19 in Thailand. The Group also announced plans to create new jobs, including hiring 20,000 new employees for food delivery services across Thailand.
  • Free delivery of food and essentials supplies to hospitals: In response to COVID-19, Charoen Pokphand Foods Public Company Limited (CPF) has provided free food delivery to 88 hospitals across Thailand. To cope with rising demand for food supply throughout Thailand, CPF has increased production capacity of certain essential food such as eggs and will ensure sufficient supplies without an increase in food prices.
  • Upgrade digital infrastructure for remote working and e-learning: C.P. Group’s telecommunications arm, True Corporation Public Company Limited (True Corporation), tripled domestic and international bandwidth capacity to provide customers with enhanced services on digital platforms for e-learning, remote working and e-payment services. To provide digital solutions that help with social distancing, True Corporation has offered free access to a cloud-based integrated solutions platform – “True Virtual World”- that was developed in less than a month during COVID-19 to support work from home arrangements and e-learning for students. True Corporation, in collaboration with CPF, is also providing free mobile phone SIM cards to suspected COVID-19 patients who register to receive free food delivery from CPF. In addition, through the Digital Council of Thailand (DCT), of which C.P. Group’s CEO Suphachai Chearavanont is President, True Corporation announced that they will work alongside other Council members to launch digital platforms and applications to help source medical supply donations as well as track, trace and contain the spread of COVID-19.

Mr. Suphachai Chearavanont, CEO of Charoen Pokphand Group, said, “During these dark times, we must unite and tackle COVID-19 together. Critical to our fight against this pandemic is to make sure our frontline medical workers have the essential medical equipment they need, and surgical masks are critical for them at this time. At this moment, we are also very focused on keeping people employed and do what we can to help our employees and their families, our customers and our local communities. With the mask factory now open along with all our other COVID-19 initiatives, we are using the best of our capability throughout the areas and sectors our Group operates in to contribute to the fight against COVID-19. Our Group was founded on the Three-Benefit Principle, which places the countries and communities in which we operate as well as our people before the company’s interest. This remains central to everything that we do, especially during difficult and challenging times.”

Mr. Soopakij Chearavanont, Chairman of Charoen Pokphand Group, said, “We are committed to fighting the COVID-19 pandemic alongside Thailand until the very end. We strongly believe that through the global partnerships we have with our network of suppliers and most importantly employees, we can pool together skills and resources as we continue our joint efforts to tackle COVID-19. We recognize that this is a challenging time for us all, and as a Group, we want to make sure we are doing everything we can to help our local communities and to support all our stakeholders. This is the right thing to do at this time and I believe by working together, we can get through this unprecedented challenge that COVID-19 has presented to all of us both locally and globally.”

Suphachai Chearavanont (center), CEO of C.P. Group, visiting the production line inside the surgical face mask factory
Suphachai Chearavanont (center), CEO of C.P. Group, visiting the production line inside the surgical face mask factory
C.P. Group Senior Chairman Dhanin Chearavanont (sixth from left), Chairman Soopakij Chearavanont (fourth from left), and CEO Suphachai Chearavanont (third from left), handed 100,000 masks to the Chulalongkorn Hospital, Thai Red Cross
C.P. Group Senior Chairman Dhanin Chearavanont (sixth from left), Chairman Soopakij Chearavanont (fourth from left), and CEO Suphachai Chearavanont (third from left), handed 100,000 masks to the Chulalongkorn Hospital, Thai Red Cross

About Charoen Pokphand Group:

The Charoen Pokphand Group (C.P. Group) is a leading Thai multi-national conglomerate that operates 3 core businesses in agro-industry and food, marketing and distribution, and telecommunications. C.P. Group invests in 21 countries with over 200 companies and 300,000 employees located around the world. The organization operates under the ‘3-Benefits’ principle of ‘Benefiting the Country, the Society and then the Company’ where ever we operate, thereby enabling C.P. Group to play a role in the development of Thailand’s economic and social development as well as all countries we have invested in. Since September 2017, three of C.P. Group’s listed businesses have been admitted to the Dow Jones Sustainability Index (DJSI) Emerging Markets, signalling C.P. Group’s long-term commitment to ensuring a sustainable future.

For more information, please visit: www.cpgroupglobal.com/en/

Photo – https://photos.prnasia.com/prnh/20200417/2779767-1-a?lang=0
Photo – https://photos.prnasia.com/prnh/20200417/2779767-1-b?lang=0